Journal article
Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America
PLoS medicine, Vol.22(5), e1004590
05/20/2025
DOI: 10.1371/journal.pmed.1004590
PMCID: PMC12091891
PMID: 40392909
Abstract
Alcohol is a known carcinogen, yet the evidence for an association with pancreatic cancer risk is considered as limited or inconclusive by international expert panels. We examined the association between alcohol intake and pancreatic cancer risk in a large consortium of prospective studies.
Population-based individual-level data was pooled from 30 cohorts across four continents, including Asia, Australia, Europe, and North America. A total of 2,494,432 participants without cancer at baseline (62% women, 84% European ancestries, 70% alcohol drinkers [alcohol intake ≥ 0.1 g/day], 47% never smokers) were recruited between 1980 and 2013 at the median age of 57 years and 10,067 incident pancreatic cancer cases were recorded. In age- and sex-stratified Cox proportional hazards models adjusted for smoking history, diabetes status, body mass index, height, education, race and ethnicity, and physical activity, pancreatic cancer hazard ratios (HR) and 95% confidence intervals (CI) were estimated for categories of alcohol intake and in continuous for a 10 g/day increase. Potential heterogeneity by sex, smoking status, geographic regions, and type of alcoholic beverage was investigated. Alcohol intake was positively associated with pancreatic cancer risk, with HR30-to-<60 g/day and HR≥60 g/day equal to 1.12 (95% CI [1.03,1.21]) and 1.32 (95% CI [1.18,1.47]), respectively, compared to intake of 0.1 to <5 g/day. A 10 g/day increment of alcohol intake was associated with a 3% increased pancreatic cancer risk overall (HR: 1.03; 95% CI [1.02,1.04]; pvalue < 0.001) and among never smokers (HR: 1.03; 95% CI [1.01,1.06]; pvalue = 0.006), with no evidence of heterogeneity by sex (pheterogeneity = 0.274) or smoking status (pheterogeneity = 0.624). Associations were consistent in Europe-Australia (HR10 g/day = 1.03, 95% CI [1.00,1.05]; pvalue = 0.042) and North America (HR10 g/day = 1.03, 95% CI [1.02,1.05]; pvalue < 0.001), while no association was observed in cohorts from Asia (HR10 g/day = 1.00, 95% CI [0.96,1.03]; pvalue = 0.800; pheterogeneity = 0.003). Positive associations with pancreatic cancer risk were found for alcohol intake from beer (HR10 g/day = 1.02, 95% CI [1.00,1.04]; pvalue = 0.015) and spirits/liquor (HR10 g/day = 1.04, 95% CI [1.03,1.06]; pvalue < 0.001), but not wine (HR10 g/day = 1.00, 95% CI [0.98,1.03]; pvalue = 0.827). The differential associations across geographic regions and types of alcoholic beverages might reflect differences in drinking habits and deserve more investigations.
Findings from this large-scale pooled analysis support a modest positive association between alcohol intake and pancreatic cancer risk, irrespective of sex and smoking status. Associations were particularly evident for baseline alcohol intake of at least 15 g/day in women and 30 g/day in men.
Details
- Title: Subtitle
- Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America
- Creators
- Linda Snetselaar - University of IowaSabine Naudin - Université de Versailles Saint-Quentin-en-YvelinesMolin Wang - Harvard UniversityNiki Dimou - Centre international de recherche sur le cancerElmira Ebrahimi - Centre international de recherche sur le cancerJeanine Genkinger - Columbia University Irving Medical CenterHans-Olov Adami - University of OsloDemetrius Albanes - National Cancer InstituteAna Babic - Dana-Farber Cancer InstituteMatt Barnett - Fred Hutch Cancer CenterDavid Bogumil - Keck Hospital of USCHui Cai - Vanderbilt UniversityChu Chen - Fred Hutch Cancer CenterA Heather Eliassen - Harvard UniversityJo L Freudenheim - University at Buffalo, State University of New YorkGretchen Gierach - National Cancer InstituteEdward L Giovannucci - Harvard UniversityMarc J Gunter - Centre international de recherche sur le cancerNiclas Håkansson - Karolinska InstitutetMayo Hirabayashi - Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, JapanTao Hou - Harvard UniversityBrian Z Huang - Keck Hospital of USCWen-Yi Huang - Division of Cancer Epidemiology and GeneticsHarindra Jayasekara - The University of MelbourneMichael E Jones - Institute of Cancer ResearchVerena A Katzke - German Cancer Research CenterWoon-Puay Koh - Singapore Institute for Clinical SciencesJames V Lacey - City Of Hope National Medical CenterYlva Trolle Lagerros - Karolinska InstitutetSusanna C Larsson - Karolinska InstitutetLinda M Liao - National Cancer InstituteKenneth Lo - Hong Kong Polytechnic UniversityErikka Loftfield - Division of Cancer Epidemiology and GeneticsRobert J MacInnis - Cancer Council VictoriaSatu Männistö - Finnish Institute for Health and WelfareMarjorie L McCullough - American Cancer SocietyAnthony Miller - University of TorontoRoger L Milne - Cancer Council VictoriaSteven C Moore - National Cancer InstituteLorelei A Mucci - Harvard UniversityMarian L Neuhouser - Fred Hutch Cancer CenterAlpa V Patel - American Cancer SocietyElizabeth A Platz - Johns Hopkins UniversityAnna Prizment - University of Minnesota Medical CenterKim Robien - Milken InstituteThomas E Rohan - Albert Einstein College of MedicineCarlotta Sacerdote - Piedmont Reference Center for Epidemiology and Cancer PreventionSven Sandin - Karolinska InstitutetNorie Sawada - Cohort (United Kingdom)Minouk Schoemaker - IQVIA, Global Database Studies, Amsterdam, The NetherlandsXiao-Ou Shu - Vanderbilt UniversityRashmi Sinha - National Cancer InstituteMeir J Stampfer - Harvard UniversityRachael Stolzenberg-Solomon - Division of Cancer Epidemiology and GeneticsCynthia A Thomson - University of ArizonaAnne Tjønneland - Danish Cancer SocietyCaroline Y Um - American Cancer SocietyPiet A van den Brandt - Maastricht UniversityKala Visvanathan - Sidney Kimmel Comprehensive Cancer CenterSophia S Wang - City Of Hope National Medical CenterRenwei Wang - UPMC Hillman Cancer CenterElisabete Weiderpass - Centre international de recherche sur le cancerStephanie J Weinstein - National Cancer InstituteEmily White - Fred Hutch Cancer CenterWalter Willett - Harvard UniversityAlicja Woslk - Karolinska InstitutetBrian M Wolpin - Harvard UniversityShiaw-Shyuan S Yaun - Harvard UniversityChen Yuan - Dana-Farber Cancer InstituteJian-Min Yuan - University of PittsburghWei Zheng - Vanderbilt UniversityPaul Brennan - Centre international de recherche sur le cancerStephanie A Smith-Warner - Harvard UniversityPietro Ferrari - Centre international de recherche sur le cancer
- Resource Type
- Journal article
- Publication Details
- PLoS medicine, Vol.22(5), e1004590
- DOI
- 10.1371/journal.pmed.1004590
- PMID
- 40392909
- PMCID
- PMC12091891
- NLM abbreviation
- PLoS Med
- ISSN
- 1549-1676
- eISSN
- 1549-1676
- Publisher
- PUBLIC LIBRARY SCIENCE
- Grant note
- R01 CA144034 / NCI NIH HHS U01 CA086308 / NCI NIH HHS P30 CA033572 / NCI NIH HHS R01 CA039742 / NCI NIH HHS UM1 CA182876 / NCI NIH HHS 75N92021D00001 / NHLBI NIH HHS U01 AG018033 / NIA NIH HHS U01 HL145386 / NHLBI NIH HHS 75N92021D00002 / NHLBI NIH HHS U01 CA063673 / NCI NIH HHS
- Language
- English
- Date published
- 05/20/2025
- Academic Unit
- Epidemiology; Fraternal Order of Eagles Diabetes Research Center; Internal Medicine
- Record Identifier
- 9984824321802771
Metrics
8 Record Views